| Title : microRNA-592 blockade inhibits oxidative stress injury in Alzheimer's disease astrocytes via the KIAA0319-mediated Keap1\/Nrf2\/ARE signaling pathway - Wu_2019_Exp.Neurol__113128 |
| Author(s) : Wu GD , Li ZH , Li X , Zheng T , Zhang DK |
| Ref : Experimental Neurology , :113128 , 2019 |
|
Abstract :
MicroRNA-592 (miR-592) has been reported to play a significant role in mediating neuronal activity, but its possible link with Alzheimer's disease (AD) remains unclear. We aimed to explore the mechanism of miR-592 in oxidative stress (OS) injury of astrocytes (ASTs) from AD rat models induced by D-galactose or Abeta25-35 injection. Bioinformatics website and dual-luciferase reporter gene assay clarified the binding affinity between miR-592 and KIAA0319. KIAA0319 was identified as a target gene of miR-592. The mechanism of miR-592, KIAA0319 and the Keap1/Nrf2/ARE signaling pathway in AD was examined after transducing miR-592 mimic, miR-592 inhibitor and siRNA-KIAA0319 into ASTs to query cell viability, OS injury and reactive oxygen species (ROS). The rat models of AD Exhibited highly expressed miR-592 and poorly expressed KIAA0319. Furthermore, inhibition of miR-592 diminished C-Keap1 expression and enhanced N-Nrf2 and NQO1 expression, thus promoting cell viability and reducing OS injury of ASTs. Taken together, these findings suggested that the downregulation of miR-592 inhibited OS injury of ASTs in rat models of AD by up-regulating KIAA0319 through the activation of the Keap1/Nrf2/ARE signaling pathway. |
| PubMedSearch : Wu_2019_Exp.Neurol__113128 |
| PubMedID: 31759899 |
Wu GD, Li ZH, Li X, Zheng T, Zhang DK (2019)
microRNA-592 blockade inhibits oxidative stress injury in Alzheimer's disease astrocytes via the KIAA0319-mediated Keap1\/Nrf2\/ARE signaling pathway
Experimental Neurology
:113128
Wu GD, Li ZH, Li X, Zheng T, Zhang DK (2019)
Experimental Neurology
:113128